¹B°Ê¥Í²z¶g°T(²Ä226´Á)
¹B°Ê«e³Ü©@°Ø¦n¶Ü¡H(August 22, 2006)
¤ý¶¶¥¿

¡@¡@¶³ªL¥j§|ªº
¥xÆW©@°Ø¸`¿ì±o¬Û·í¦¨¥\¡A¤]±a°Êªºªþªñªº©@°Ø²£·~(¥j§|µØ¤s¦³¡u¶³ªL¶§©ú¤s¡v¶®ºÙ¡A¬O¥xÆW©@°Øªºì¶m¡A¤]¬O¥xÆW©@°Ø¦A¥Í·nÄx¡I¥Rº¡Å]¤Oªº©@°Ø¨§©M½AÀö©]´º¡A¨C¦~¬°³o¬üÄR¤s§ø±a¨Ó¤W¦Ê¸U¤H¦¸Æ[¥ú¤H¼é¥H¤Î¼Æ¤Q»õ¤¸°Ó¾÷ )¡C¡u¥j§|ªº©@°Ø®â´Ó©ó²üc¤s¤W¡A¦ì©ó®ü©Þ¤T¦Ê¤½¤Øªº²üc¤s¡AÄݱƤô¨}¦n¤§¨F½è¤gÄ[¡A¦A¥[¤W³B©ó¨È¼ö±a®ðÔ°Ï¡A«D±`¾A¦X©@°Øªº¥Íªø¡A¥j§|ªº©@°Ø¦b¥xÆW¤w¸g¨É¦³ª¾¦W«×¡A©@°Ø³Ü°_¨Ó¥Ì¾J²¢¬ü¡A¤ñ°ê¥~ªº©@°Ø§ó¨ã¥xÆW¿W¯Sªº·¨ý¡C¡v¦b¤j®a¼ö¯Pªº±À®i¥xÆW©@°Ø¤å¤Æ¡B¥xÆW©@°Ø²£·~ªº¦P®É¡A¬O¤£¬O¤]À³¸ÓÁA¸Ñ¤@¤U³Ü©@°Ø¹ï©ó¤HÅé¥Í²zªº¼vÅT¡H¯S§O¬O¹ï©ó¹B°Ê°Ñ»PªÌ³Ü©@°Ø¦n¤£¦nªººÃ°Ý©O¡H

¡@¡@¦Û¤µ¦~(2006)¤K¤ë¤@¤é°_¡A¦æ¬F°|½Ã¥Í¸p³W©w§t©@°Ø¦]ªº¥]¸Ë¶¼«~¡A¥~¥]¸Ë¤W¥²¶·¼Ð¥Ü©@°Ø¦]§t¶q¡A¬õ¼Ð¥Nªí©@°Ø¦]§t¶q¦b¨â¦Ê¦Ü¤T¦Ê²@§J¡A©Î¤T¦Ê²@§J¥H¤W¡F¶À¼Ð¥Nªí§t¶q¦b¤@¦Ê¦Ü¨â¦Ê²@§J¡Fºñ¼Ð¥Nªí§t¶q¦b¤@¦Ê²@§J¥H¤U¡C³q±`¡A¸q¦¡¿@ÁY©@°Ø¡A¤p¤p¤@ªM¤T¤QCC¡A©@°Ø¦]§t¶q¦³¤»¤Q¤²@§J¡F¡u¬ü¦¡©@°Ø¡v¥|¦Ê¤K¤QCCªº¤jªM¥÷¶q¤¤¡A¬ù¦³¤@¦Ê¤E¤Q¤²@§Jªº©@°Ø¦]¡F¡u®³ÅK¡v¤Î¡uµJ¿}º¿©_¦·¡v¤f¨ý¡AÁöµM¥[¤J¤F¤j¶qªº¤û¥¤¤ÎµJ¿}¡A¨ý¹DÅã±o¬X©M³\¦h¡A¦ý©@°Ø¦]¤]¤£®e¤pòó¡A¥|¦Ê¤K¤QCCªº¤jªM¥÷¶q¡AÁÙ¬O¦³¤@¦Ê¤T¤Q²@§J¡CÂå®v´£¿ô¡A¤£·Q³Ü©@°Ø³Ü¥X¯f¡A©@°Ø¦]Äá¨ú³Ì¦n¨C¤Ñ¤£¶W¹L¤¦Ê²@§J¡A©ÎªÌ¨C¤½¤çÅ髤£nÄá¨ú¶W¹L¤¦Ü¤»²@§Jªº©@°Ø¦]¡C
¡@¡@¹B°Ê«e«á³Ü©@°Ø¦n¶Ü¡H¨ä¹ê¦b¹B°Ê¥Í²z¾Çºô¯¸ªº°Q½×°Ï¤¤¡A¦³¤@½g¡u
ªø´Á¶¼¥Î©@°Ø·|¼vÅT½m²ß©MÃÄÀ˶Ü?¡vªº°Q½×¥i¥H´£¨Ñºô¤Í°Ñ¦Ò¡C¨Ì¾Ú
Andes_Chengªº¦^À³«ü¥X¡A¡u¦b1984¦~®É¡A©@°Ø´¿³Q°ê»Ú¶ø©e·|(IOC)¦C¬°¸TÃÄ¡A¹H³W¾¯¶q¬°800mg(¦b2~3¤p®É¤º¡A¬ù»Ý³Ü5¦Ü6ªMªº¿@©@°Ø)¡C¤£¹L¡A¦b2004.1.1¤w±N©@°Ø²¾°£©ó¸TÃĦW³æ¡v¡C¤]´N¬O»¡¡A¦³¤@¬q®É¶¡©@°Ø¦b¹B°Ê³õ¤W¬O¸TÃÄ¡A¹B°Êû¤£¯à¤j¶qªºÄá¨ú¡A¬Û¹ïªº¤]¥NªíÄá¨ú¤Ó¦h¥i¯à¦M®`¨Åé©Î³y¦¨¤ñÁɪº¤£¤½¥¡C
Andes_Cheng¦P®É¤]´£¨ì¡A¤@¯ë¶¼®Æ§t©@°Ø¦]ªº±¡§Î¤jP¦p¤U¡A1ªM©@°Ø(©@°ØªM)¬ù§t100~150mg¡A1ªM¯ù¬ù§t20~50mg¡A1Åø¥i¼Ö¬ù§t35~55mg¡A1Åø°ª©@°Ø¦]ªº¨T¤ô¬ù§t55-110mg¡C«Ü¦h¤H³Ü©@°Øªº®ÉÔ¡A¨Ã¨S¦³¯S§O¦Ò¶q¨ì©@°Ø¦]ªº°ÝÃD¡A¬Æ¦Ü³Ü¯ù¡B¥i¼Ö¡B¨T¤ôµ¥¶¼®Æ¡A¤j¶q¶¼¥Î®É¡A¤]³£·|¦]¬°©@°Ø¦]¦Ó¦M®`¨Åé°·±d¡C
¡@¡@
Andes_Chengªº¦^À³¤]«ü¥X¡A®Ú¾ÚWilliams(2005)ªºNutrition for health, fitnee & sport¤@®Ñ¤¤©Ò´£¡AÄá¨ú©@°Ø¦]ªº®ÄªG¡G¨ë¿E¤¤¼Ï¯«¸g¨t²Î¡A¼W¥[ĵı©Ê¡A§ïµ½Â²³æ°Ê§@ªº¤Ï®g®É¶¡(¾¯¶q200 mg)¡A¾¯¶q°ª©ó400 mg®É¡A«h·|¼W¥[µJ¼{»P¯«¸g½è¦Ó¼vÅT¹B°Êªí²{¡C¨ë¿E¦Ù¼ßºôÄÀ¥X¶tÂ÷¤l¡A¼W¥[¦Ù¦×¦¬ÁY¤O¡C¦³§U©ó°ª±j«×¹B°Êªí²{¡A¥i¯à»P¤ß²z§@¥Î¦³Ãö¡C¨ë¿E¤ßŦ¥\¯à¡B¦å²G´`Àô¥H¤ÎµÇ¤W¸¢¯ÀªºÄÀ¥X¡C¨ë¿E¯×ªÕ²ÓMÄÀ¥X´åÂ÷¯×ªÕ»Ä(free fatty acids)¡A¦Ó´£¤É¥ð®§®É¦å²G¤¤FFA¿@«×¡C¨ë¿E¦Ù¦×»P¨xŦ¤¤ªº¨xÁÞ¤À¸Ñ¡C¼W¥[¦Ù¦×¤¤¤T»Ä¥Ìªoà(triglycerides)ªº¨Ï¥Î(³Ìªñªº¬ã¨sµo²{¡A¦bªø®É¶¡¹B°Ê®É¡A©@°Ø¦]¨ÃµLªk«P¶iFFAªº¨Ï¥Î¥H¤Î¸`¬Ù¨xÁÞªº¨Ï¥Î)¡C«P¶i@¤O©Ê¹B°Êªí²{(¹B°Ê«e1¤p®ÉÄá¨ú)¡A»P¨ë¿EµÇ¤W¸¢¯À¤Àªc¡Bĵı©Ê¤Î±¡ºü¦³Ãö¡C¨Ï¥Î©@°Ø¦]°µ¼W¸É¾¯¤§«e¡A»Ý¥ý§ÙÂ_2~4¤Ñ¡C©@°Ø¦]»P³Â¶À¯À¦X¨Ö¨Ï¥Î(¾¯¶q¡Gcaffeine4-5mg/kg¡Aephedrine0.8-1.0mg/kg)¡A¥i©úÅã«P¶iµL®ñ»P¦³®ñ¹B°Êªí²{¡C³Â¶À¯ÀÄݹB°Ê¸TÃÄ¡A¦Ó§t³Â¶À¦¨¤Àªºpseudoephedrine»Pphenlpropanolamine¨Ã«D¸TÃÄ¡A¦ýpseudophedrineªºÄá¨ú¾¯¶q¥un¹F³Â¶À¯Àªº2.5¿§Y¥iÀò±o¬Û¦üªº®ÄªG¡A¥ç§Y2-2.5 mg/kg¡C©@°Ø¦]¬O¤@ºØ§Q§¿¾¯¡A¦ý¥Ø«eªº¬ã¨sÅã¥Ü¡A¥un§¡¿Å¶¼¹¡A©@°Ø¦]¨Ã¤£·|§ïÅܱƦ½¶q¡B¦å¼ß¶q»PÅé·Å¡C©@°Ø¦]Äá¨úªº¼vÅT¨ã¦³Ó§O®t²§¡C¦b¹ê»ÚÀ³¥Î©ó¤ñÁɤ§«e¡A³Ì¦n¦Û¤v¥ý¦æ°µ¸ÕÅç(¦Û¦æ¤ñ¸û©Î¥Ñ§O¤HÀH¾÷µ¹ÃÄ¡A°O¿ý¦Û¤vªº¤ÏÀ³)¡C
¡@¡@
Andes_Cheng«ü¥X©@°Ø¦]ªº°Æ§@¥Î¤è±¡C¦³¨Ç¤H·|µo¥Í¤ß«ß¤£¾ã¡B¦åÀ£¼W¥[ªº±¡§Î¡C¥Ø«e»{¬°»P«aª¬°Ê¯ß¤ßŦ¯e¯f(coronary artery disease)ªºµo¥ÍµL©úÅãÃö³s¡A¨C¤Ñ3ªM(6-9¯s¥q)¥ª¥k¡A¹ï¤j³¡¤Àªº¤H¤£·|¦³¼vÅT¡C¥Ø«e»{¬°§t©@°Ø¦]ªº¶¼®Æ¨Ã¤£·|PÀù¡C©@°Ø¦]¤£·|³y¦¨¨Å©ÐªºÅÖºû¤Æ¡C©@°Ø¦]Áö·|¨Ï¶t½è¬y¥¢¡A¦ýÄÝ«D±`¤Ö¶q(¨CªM¬ù¬y¥¢5mg)¡A¥un¥[¤J2´ö°Íªº¤û¥¤§Y¥i¸Ñ¨M¡A¦ý«ØÄ³Yn³Ü©@°Ø¡A¤´n³Ü¤û¥¤©ÎÄá¨ú´I§t¶t½èªº¹ª«¡C·í¨C¤ÑÄá¨ú¶W¹L150mg®É¡A·|¼W¥[¬y²£»PL¨àÅ髹L»´ªº·ÀI¡C¥i¼W¥[¥ð®§¥NÁ²v(resting metabolic rate)¬ù10%¡A¨Ã«ùÄò¼Æ¤p®É¡A¦³§U©ó´î«¡C¥i¯à·|³y¦¨¥¢¯v¡C¦³¨Ç¤H·|¦³G³¡¤£¾A(¨ë¿EG»Ä¤Àªc)¡C¤£±`³Ü©@°ØªÌ¡A¦bÄá¨ú¤¤¾¯¶q®É¡A¥i¯à·|¥X²{¯«¸g½è¡B·Ðļ¡BÀYµh©Î¥¢¯v¡C¥i¯à·|µo®i¦¨¨ã¦³©@°Ø¦]¨Ì¿à©Ê(©@°Ø¦]¤¤¬r¯g)¡C¾ãÅé¦Ó¨¥¡A©@°Ø¦]ÄÝ©ó¦w¥þªº¡uÃĪ«¡v¡C
¡@¡@¦³Ãö©@°Ø¦]Äá¨ú»P¦å¯×ªÕ¿@«×ªº¬ÛÃö¬ã¨s¤è±¡C§d¼y·ç(1994)±´°Q¦b¹B°Ê«e¤@¤p®ÉÄá¨ú©@°Ø(©@°Ø¦]3 mg/kgÅé«)»P¥Õ¶}¤ô«á¡A¥H50%VO
2max½ò½ñ¤E¤Q¤ÀÄÁ¸}½ñ¨®¹B°Ê¹ï¦å¯×ªÕ¤Î¦å¯×³J¥Õªº«æ©Ê¼vÅT¡C¬ã¨sµo²{Äá¨ú©@°Ø¹B°Ê«á¡A¤T»Ä¥Ìªo¯×¦³ÅãµÛ°ª©óÄá¨ú¥Õ¶}¤ô¹B°Ê«á¡A¦ýÁ`Áx©T¾J©M¯×³J¥Õ§¡¨S¦³¼vÅT¡C¨ä¹ê¡A´X¥G©Ò¦³ªº¬ã¨s³ø§i³£«ü¥X¡AÄá¨ú©@°Ø¦]¥i¥HÅãµÛ¼W¥[¦å¤¤´åÂ÷¯×ªÕ»Äªº¿@«×¡C©@°Ø¦]·|§í¨îÁC»ÄªGÁÞ¿E酶(phosphofructokinase)¤Î¤þ଻IJæ²B酶(pyruvate dehydrogenase)¡A«P¶i¯×ªÕ®ñ¤Æªº³t«×¼W¥[¡A¨Ï¦å¤¤´åÂ÷¯×ªÕ»Ä¿@«×¼W¥[¡A¦P®É©@°Ø¦]¤]·|¨ë¿E¯×ªÕ²ÓM¤ºªºc-AMP¿@«×´£°ª¡A¼W¥[¯×¸Ñ§@¥Î¡A¶i¦Ó«P¦¨¦å¯×ªÕ»P¤T»Ä¥Ìªo¯×¦bÄá¨ú©@°Ø«áÅãµÛªº´£°ª(§d¼y·ç¡A1994)¡C

¡@¡@¦³Ãö©@°Ø¦]Äá¨ú»P¹B°Êªí²{ªº¬ÛÃö¬ã¨s¤è±¡CStuart, Hopkins, Cook, and Cairns(2005)«h±´°Q¾ñÆV²y¿ï¤âÄá¨ú©@°Ø¦]6mg/kgÅé«(¦³¦w¼¢¾¯²Õ)¡A¹ï©ó90¤ÀÄÁ(¤W¤U¥b³õ¦U40¤ÀÄÁ¡B¤¤³õ¥ð®§10¤ÀÄÁ)¾ñÆV²y´úÅç(rugby test)µ²ªGªº¼vÅT¡A¬ã¨sµo²{¶Ç²y·Ç½T«×(passing accuracy)¡B30¤½¤Ø½Ä¨ë¡B³Ì¤j°Ê¤O(peak power)´úÅçµ¥¡A·|¨ü¨ì©@°Ø¦]Äá¨úªºÅãµÛ¼W¶i¡A¤U¥b³õ¦A´úÅç®É(¯h³Òªº®ÄªG)¡A³o¨Ç´úÅ窺µ²ªG¤]·|ÅãµÛÀu©óÄá¨ú¦w¼¢¾¯®É¡C¨ü´úªÌ¦b´úÅç¹Lµ{¤¤¡A¦å¤¤©@°Ø¦]¿@«×»PµÇ¤W¸¢¯À(epinephrine)¿@«×³£¦³ÅãµÛ¤Wª@ªº²{¶H(¥k¹Ï)¡F©@°Ø¦]ªºÄá¨ú¤£¶È¹ïªø®É¶¡ªº@¤O©Ê¹B°Ê¦³©Ò§U¯q¡AÁÙ¹ïµu®É¶¡Àþµo©Êªº¹B°Ê¯à¤O¦³¼W¶i®ÄªG¡CBell and Mclellan(2003)«hµo²{¤W¤È»P¤U¤È(¶¡¹j6¤p®É)Äá¨ú©@°Ø¦]5mg/kgÅ髩Φw¼¢¾¯(¤À¬°ABCD¥|²Õ¶i¦æ¡AA²Õ¤W¤U¤È³£Äá¨ú©@°Ø¦]¡AB²Õ¤W¤U¤È³£Äá¨ú¦w¼¢¾¯¡AC²Õ¤W¤ÈÄá¨ú©@°Ø¦]¡B¤U¤ÈÄá¨ú¦w¼¢¾¯¡AD²Õ¤W¤ÈÄá¨ú¦w¼¢¾¯¡B¤U¤ÈÄá¨ú©@°Ø¦])¡A¹ï©ó¤U¤È¶i¦æ80%VO
2maxªº«ùÄò¹B°Ê®É¶¡¤´µM¦³ÅãµÛªº¼W¶i¡A¤]´N¬O»¡¦¤WÄá¨úªº©@°Ø¦]¡A¥i¥H¦³®Äªº¼W¶i¤U¤È(¶¡¹j6¤p®É)ªº@¤O¹B°Êªí²{¡CSchneiker, Bishop, Dawson, and Hackett(2006)³z¹LÂùª¼(double-blind)»P¦w¼¢¾¯±±¨î(placebo-controlled)ªº¹êÅç³]p¤U¡AÄá¨ú6mg/kgÅé««á¡A¥i¥HÅãµÛ´£ª@ªø´Á¶¡·²½Ä¨ë¯à¤O(prolonged intermittent-sprint ability)¡C¦³¤£¤Ö¬ã¨s³ø§iÅã¥Ü¡AÄá¨ú©@°Ø¦]¥i¥H¼W¶i¹B°Êªí²{¡CKalmar(2005)ªº¤å³¹¤¤¤]ÃÒ¹ê©@°Ø¦]¹ï©ó¦Ù¦×ªº¬¡°Ê¨ã¦³ÅãµÛªº¼vÅT¡A¦]¦¹«ØÄ³¶i¦æ¤HÅé¹B°Êªí²{ªº¹êÅç®É¡A¦³¥²n¨î©@°Ø¦]ªºÄá¨ú¡C
¡@¡@¬Û¤Ïªº¡ABruceµ¥(2003)«hµo²{¡A¦E²î¿ï¤âÄá¨ú©@°Ø¦]6mg/kgÅé«¡B9mg/kgÅé««á¡A¬Û¸û©óÄá¨ú¦w¼¢¾¯«á¡A·|¦³¸û°ªªº¦å¤¤´åÂ÷¯×ªÕ»Äªº¿@«×¡A¦ý¬O¦b2000¤½¤Ø¦E²îªí²{¤W«h¨S¦³ÅãµÛ¤£¦P¡CTurley and Gerst(2006)«h±´¨s7¦Ü9·³ªº¤pªB¤ÍÄá¨ú©@°Ø¦]5mg/kgÅé«(©Î¦w¼¢¾¯)¡A¨Ã¤£·|§ïÅÜ25watts»P50watts½ñ¨®¹B°Ê®ÉªºÄá®ñ¶q»P©I§l¥æ´«²v(»PÄá¨ú¦w¼¢¾¯®É¤ñ¸û)¡A¦ý¬O·|ÅãµÛ¼vÅT¤ß¸õ²v»P¦åÀ£¡C¾¨ºÞ¡A¦³¤j³¡¤Àªº¬ã¨s³ø§iÃÒ¹ê¡AÄá¨ú©@°Ø¦]¹ï©ó¹B°Êªí²{¨ã¦³ÅãµÛªº¼W¶i®ÄªG¡A¦ý¬O¤´µM¦³¬ã¨sÅã¥Ü¡A©@°Ø¦]ªº¥Í²z¼vÅT¤£¨¬¥H¼W¶i¹B°Êªí²{¡C
¡@¡@¦³©@°ØÄá¨ú²ßºDªº¤H¡A¹ï©óÄá¨ú©@°Ø¦]ªº¼vÅT·|¤£·|¤£¦P©O¡HFisher, McMurray, Berry, Mar, and Forsythe(1986)ªº¬ã¨sµo²{¡A¦³©@°ØÄá¨ú²ßºDªÌ(habitual caffeine user)Äá¨ú©@°Ø¦]5mg/kgÅ髪º¥Í²z¼vÅT·|ÅãµÛªº°§C¡A¸g¹L4¤Ñªº°±¤îÄá¨ú©@°Ø¦]«á¡A¦A«×Äá¨ú©@°Ø¦]ªº¥Í²z¼vÅT´N·|¦A«×§e²{¡CHetzler, Warhaftig-Glynn, Thompson, Dowling, and Weltman(1994)¬ã¨s²ßºD³Ü©@°Ø(¨C¤Ñ¥§¡Äá¨ú674¡Ó128mg)ªº¨k©Ê¶]ªÌ¡A²¾°£©@°ØÄá¨ú¨â¤Ñ«e«á¡A¦b¨Å»ÄìHÈ(lactate threshold)³t«×¤U¶]¨B®ÉªºÄá®ñ¶q¡B©I§l¥æ´«²v¡B¦å¤¤´åÂ÷¯×ªÕ»Ä¿@«×µ¥³£¨S¦³ÅãµÛªº¤£¦P¡A¦å¤¤¥Ìªo(glycerol)¿@«×«h¦³ÅãµÛªº´î¤Ö¡CDodd, Brooks, Powers, and Tulley(1991)°w¹ï9¦W¨C¤ÑÄá¨ú300mg¥H¤W»P8¦W¨C¤Ñ25mg¥H¤Uªº¸g±`¹B°Ê¨k©Ê¡AÄá¨ú¦w¼¢¾¯¡B©@°Ø¦]3mg/kgÅé«»P5mg/kgÅé««á¡A¶i¦æº¥¼W±j«×ªº³Ì¤j§V¤O¹B°Ê´úÅç¡Aµo²{µL®ñìHÈ»P³Ì¤jÄá®ñ¶q³£¤£·|¦]¬°Äá¨ú©@°Ø¦]¦Ó¦³ÅãµÛªº®t²§¡A¦ý¬O¦å¤¤´åÂ÷¯×ªÕ»Ä¿@«×«h¦³²ßºD©@°Ø²ÕÅãµÛ¸û°ªªº²{¶H¡C¹ï©ó¦³³Ü©@°Ø²ßºDªº¤H¨Ó»¡¡A¹B°Ê«eÄá¨ú©@°Ø¡A¦ü¥G¨Ã¤£·|´£ª@¹B°Êªí²{¡C
¡@¡@©@°Ø¦]¦b¶¼®Æ²£«~¤¤¬Û·í´¶¹M¡A¿@«×«h®t§O«Ü¤j¡C¤@¯ë¤H¥unÀH¤â¶R¤F¤@²~¶¼®Æ¡A¥i¯à´N·|Äá¨ú¨ì©@°Ø¦]¡C¦A¥[¤W©@°Ø¤å¤Æ¦b°Ó·~ªº±À°Ê»P¤å¤H¼g§@ªºµo»Ã¤U¡AÅý©@°Øªº¡uÅ}¡v(¤ß²z¤W©Î¥Í²z¤W³£¦³¥i¯à)³vº¥¦b¥xÆWªÀ·|¤¤½¯©µ(¤]¬O¥xÆW¹A·~¥ð¶¢¤å¤Æ)¡C¤£ºÞ§A¬O§_¦³³Ü©@°Øªº²ßºD¡A¦b°Ñ»P¹B°Ê¤§«e¡A³Ü¤@ªM©@°Ø¨ÃµL¤£§´¡A¥u¬O¦pªG¯à°÷ÁA¸Ñ¤@¤UÄá¨ú©@°Ø¦]¹ï©ó¹B°Ê®É¥Í²zªº¼vÅT¡Aµ´¹ï¬O¬Û·í¤£¿ùªº°·±dª¾ÃÑ»P·§©À¡C¥ô¦ó¬ü¨ý(³Ü¡B¦Y)¤Ó¦h³£¤£¦n¡A³Ü©@°Ø¤]¬O¤@¼Ëªº¹D²z¡C
°Ñ¦Ò¸ê®Æ¡G
§d¼y·ç(1994)¡C«ùÄò¹B°Ê«eÄá¨ú©@°Ø¹ï¹B°Ê«e«á¤HÅ餤¦å¯×¤Î¦å¯×³J¥Õ¤§¼vÅT¡CÅé¨|¾Ç³ø¡A17¡A391-410¡C
¹B°Ê¥Í²z¾Çºô¯¸(2002)¡C
ªø´Á¶¼¥Î©@°Ø·|¼vÅT½m²ß©MÃÄÀ˶Ü?¡C
Bell, D. G., & Mclellan, T. M. (2003). Effect of repeated caffeine ingestion on repeated exhaustive exercise endurance. Medicine and Science in Sports and Exercise,35(8),1348-1354.
Bruce, C. R., Anderson, M. E., Fraser, S. F., Stepto, N. K., Klein, R., Hopkins, W. G., & Hawley, J. A. (2000). Enhancement of 2000-m rowing performance after caffeine ingestion. Medicine and Science in Sports and Exercise,32(11),1958-1963.
Dodd, S. L., Brooks, E., Powers, S. K., & Tulley, R. (1991). The effect of caffeine on graded exercise performance in caffeine naive versus habituated subjects. European Journal of Applied Physiology,62(6),424-429.
Fisher, S. M., McMurray, R. G., Berry, M., Mar, M. H., & Forsythe, W. A. (1986). Influence of caffeine on exercise performance in habitual caffeine users. International Journal of Sports Medicine,7(5),276-280.
Hetzler, R. K., Warhaftig-Glynn, N., Thompson, D. L., Dowling, E., & Weltman, A. (1994). Effects of acute caffeine withdrawal on habituated male runners. Journal of Applied Physiology,76,1043-1048.
Kalmar, J. M. (2005). The influence of caffeine on voluntary muscle activation. Medicine and Science in Sports and Exercise,37(12),2113-2119.
Schneiker, K. T., Bishop, D., Dawson, B., & Hackett, L. P. (2006). Effects of caffeine on prolonged intermittent-sprint ability in team-sport athletes. Medicine and Science in Sports and Exercise,38(3),578-585.
Stuart, G. R., Hopkins, W. G., Cook, C., & Cairns, S. P. (2005). Multiple effects of caffeine on simulated high-intensity team-sport performance. Medicine and Science in Sports and Exercise,37(11),1998-2005.
Turley, K. R., & Gerst, J. W. (2006). Effects of Caffeine on Physiological Responses to Exercise in Young Boys and Girls. Medicine and Science in Sports and Exercise,38(3),520-526.